Verified email-pattern data for Synact Pharma is currently limited. You can still use the company insights and contact sections below.
SynAct Pharma is a biotech company aiming at resolving inflammation by leveraging melanocortin biology. Our lead asset AP1189 is in phase 2 development for the treatment of rheumatoid arthritis. AP1189 is an immunomodulatory small molecule delivered as a once-daily tablet. The mode of action is selective melanocortin receptor type 1 and 3 agonism, making it first-in-class. Activation of these receptors results in reduced secretion of proinflammatory cytokines by neutrophils and in conversion of macrophages towards clearing away cellular debris in hyper-inflamed tissue – two effects that together induce resolution of inflammation. The Phase 2a BEGIN study in patients with rheumatoid arthritis reported very promising efficacy and safety results in November 2021 - next step is to open an IND with FDA to get advice on further development.
Due to the known Mode of Action, then AP1189 was also tested in COVID-19 positive patients with respiratory insufficiency. Results were reported in July 2021, demonstrating 4 days earlier respiratory recovery, 3 days earlier hospital discharge and more than 50% reduced risk of progressing to needing mechanical ventilation.
Company Details
- Employees
- 11
- Founded
- -
- Address
- Medicon Village Ab, Sheelevägen 2, Lund,se-223 81,sweden
- Industry
- Biotechnology Research
- Website
- http://www.synactpharma.com
- Keywords
- Inflammation, Melanocortins, COVID-19, Rheumatoid Arthritis, Nephrotic Syndrome, Biotechnology.
- HQ
- Lund
Synact Pharma Questions
SynAct Pharma's website is http://www.synactpharma.com
SynAct Pharma's LinkedIn profile is https://se.linkedin.com/company/synact-pharma
SynAct Pharma has
11 employees.
View email and phone details for 11
employees at SynAct Pharma.
SynAct Pharma's industry is
Biotechnology Research
SynAct Pharma's top competitors are
Cereno Scientific,
Toleranzia Ab,
Resother Pharma,
Tetra Pharm Technologies,
Biostock - Connecting Innovation And Capital,
Irlab Therapeutics Ab,
Alzinova Ab,
Stayble Therapeutics,
Pila Pharma,
Cantargia Ab.
SynAct Pharma's categories are Biotechnology Research
SynAct Pharma's founding year is 2013
Explore related pages
Related company profiles:
Top SynAct Pharma Employees
-
-
-
Kirsten Harting
Md & Emba I Pharma & Biotech I Cmo I…
Copenhagen, Capital Region Of Denmark, Denmark, Denmark3dadlnet.dk, pfizer.com, pharma-business.dk -
Thomas Boesen
Chief Operating Officer At Synact Pharma
Copenhagen, Capital Region Of Denmark, Denmark, Denmark3medchem.dk, novonordisk.com, synactpharma.com
Free Chrome Extension
Find emails, phones & company data instantly
Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Aero Online
Your AI prospecting assistant
Select data to include:
Total price:
$0.00
0 records × $0.02 per record
How It Works
Get a Free Account
Sign up for a free account. No credit card required. Up to 10 free credits.
Search the #1 Contact Database
Get contact details of over 750M+ profiles across 60M companies – all with industry-leading accuracy. Sales Navigator and Recruiter users, try out our Email Finder Extension.
Use our AI-Powered Email Finder
Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.